Inhibition of the p38 Kinase Suppresses the Proliferation of Human ER-Negative Breast Cancer Cells

Lü Chen, Julie Ann Mayer, Tibor I. Krisko, +4

Cancer Research

Breast OncologyChemoprevention StrategyP38 KinaseCell DeathP38 Blockade +15

BRAF Inhibition Stimulates Melanoma-Associated Macrophages to Drive Tumor Growth

Tao Wang, Min Xiao, Yingbin Ge, +19

Clinical Cancer Research

Pregnane X receptor mediates sorafenib resistance in advanced hepatocellular carcinoma

Fan Feng, Qiyu Jiang, Shuang Cao, +16

Biochimica et Biophysica Acta (BBA) - General Subjects

OncologyHepatologyMedicinePathologyLiver Cancer +6

Enhanced Binding and Killing of Target Tumor Cells by Drug-Loaded Liposomes Modified with Tumor-Specific Phage Fusion Coat Protein

Tao Wang, Gerard G. M. D’Souza, Deepa Bedi, +5

Nanomedicine

Complimentary mechanisms of dual checkpoint blockade expand unique T-cell repertoires and activate adaptive anti-tumor immunity in triple-negative breast tumors

Erika J. Crosby, Jun-Ping Wei, Xiao Yang, +10

OncoImmunology

Adaptive Anti-tumor ImmunityTcr ExpansionBreast OncologyImmunologyImmunoediting +22

Enhanced tumor delivery and antitumor activity in vivo of liposomal doxorubicin modified with MCF-7-specific phage fusion protein

Tao Wang, William C. Hartner, James W. Gillespie, +5

Nanomedicine Nanotechnology Biology and Medicine

Cell-based Drug DeliveryNanomedicineDrug TargetingNanotherapeuticsAntitumor Activity +12

miR‐200c/Bmi1 axis and epithelial–mesenchymal transition contribute to acquired resistance to <scp>BRAF</scp> inhibitor treatment

Shujing Liu, Michael T. Tetzlaff, Tao Wang, +18

Pigment Cell & Melanoma Research

Braf-mutant MelanomasEpithelial–mesenchymal Transition ContributeImmunologyCancer BiologyTumor Biology +15

Rational design of affinity peptide ligand by flexible docking simulation

Fufeng Liu, Tao Wang, Xiaoyan Dong, +1

Journal of Chromatography A

BiochemistryProtein FoldingMedicinePeptide EngineeringAffinity Peptide Ligand +4

Landscape phage fusion protein-mediated targeting of nanomedicines enhances their prostate tumor cell association and cytotoxic efficiency

Prashanth K. Jayanna, Deepa Bedi, James W. Gillespie, +5

Nanomedicine Nanotechnology Biology and Medicine

NanomedicineDrug TargetingEngineeringNanomedicines EnhancesPolymer-drug Conjugate +8

Generation of a safe and efficacious llama single-domain antibody fragment (vHH) targeting the membrane-proximal region of 4-1BB for engineering therapeutic bispecific antibodies for cancer

Tianhang Zhai, Chao Wang, Yifeng Xu, +16

Journal for ImmunoTherapy of Cancer